Efficacy Results of a 52-week Trial of Adalimumab in the Treatment of Refractory Sarcoidosis. Sarcoidosis, Vasculitis and Diffuse Lung Diseases, [S. l.], v. 31, n. 1, p. 46–54, 2014. Disponível em: https://www.mattioli1885journals.com/index.php/sarcoidosis/article/view/2943.. Acesso em: 27 apr. 2024.